NIH Ethics Program - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

NIH Ethics Program

Description:

A biotechnology or pharmaceutical company; a medical device manufacturer; or a ... sector mutual fund that focuses its investments in pharmaceutical companies. ... – PowerPoint PPT presentation

Number of Views:33
Avg rating:3.0/5.0
Slides: 27
Provided by: franp
Category:
Tags: nih | ethics | program

less

Transcript and Presenter's Notes

Title: NIH Ethics Program


1
NIH Ethics Program
  • Supervisor Training
  • Reviewing the HHS-716
  • November 2005

2
What is a Substantially Affected Organization?
  • A substantially affected organization (SAO) is
    defined in 5 CFR 5501 and includes
  • A biotechnology or pharmaceutical company a
    medical device manufacturer or a corporation,
    partnership, or other enterprise or entity
    significantly involved, directly or through
    subsidiaries, in the research, development, or
    manufacture of biotechnological, biostatistical,
    pharmaceutical, or medical devices, equipment,
    preparations, treatments, or products
  • Any organization a majority of whose members are
    described above and
  • Any other organization determined by the
    designated agency ethics official or, in
    consultation with the designated agency ethics
    official, by the NIH Director or the NIH
    Directors designee that is substantially
    affected by the programs, policies, or operations
    of the NIH.

3
Why must the HHS-716 be filed?
  • The revised HHS Supplemental Standards of Ethical
    Conduct require certain NIH employees to file the
    HHS-716 (5 CFR 5501.109) and
  • Filing provides the NIH with an opportunity to
    confirm no conflict between official duties and
    financial interests by reviewing the holdings of
  • NIH Senior employees, to also confirm that the
    holdings meet the regulatory requirement and
  • Other covered NIH employees.

4
Who must file the HHS-716?
  • All NIH employees who
  • File the Public Financial Disclosure Report
    (SF-278), or
  • File the Confidential Financial Disclosure Report
    (OGE-450) or
  • Are designated as Clinical Investigators
    regardless of whether they file a financial
    disclosure report. Clinical investigators are all
    employees listed on the cover page of the NIH
    form 1195 as of August 31, 2005 (excluding those
    individuals who are not FTEs).

5
What are the limits for holdings?
  • Non-Senior NIH employees and their spouses and
    minor children may hold financial interests in a
    substantially affected organization (SAO) without
    limit AS LONG AS THERE IS NO CONFLICT OF INTEREST
    WITH THE EMPLOYEES OFFICIAL DUTIES.
  • Senior employees and their spouses and minor
    children generally may hold up to a total of
    15,000 in a substantially affected organization
    (SAO), with certain exceptions.

6
What is a conflict of interest?
  • A conflict of interest exists when an employee
    has divided loyalty as defined by law, i.e.,
    being in a situation where an official decision
    will affect a personal or imputed financial
    interest (financial interests of spouse, minor
    child, and other covered relationships).

7
Conflict Examples
  • An investigator on a drug trial holds stock in
    either the company supplying the drug or the
    companys competitor.
  • An investigator on a drug trial owns shares in a
    health sector mutual fund that focuses its
    investments in pharmaceutical companies.

8
Conflict Examples, cont.
  • An extramural program officials spouse owns a
    small biotech company which is applying for a
    Small Business Innovation Research grant and the
    grant is assigned to that program official.
  • An extramural program official awards a contract
    to a company and he has stock options in that
    companys competitor.

9
How do I review the HHS-716?
  • Supervisors (and in some cases the Principal
    Investigator) review those subordinates HHS-716
    forwarded by the IC Ethics Office after a
    threshold determination by the DEC that a
    analysis under section 208 is required.
  • Supervisors (and PIs) will NOT see values, only
    the names of the holdings.

10
Employees Section of the Form
  • Part III, Box 1

11
Supervisory Review, cont.
  • Supervisors will
  • examine the employees current official duties,
    and identify the outside organizations with which
    the employee works in an official capacity (the
    party)
  • determine whether there are other organizations
    (i.e., competitors) which can also be affected by
    the employees current official duties (the
    non-parties) and
  • compare those affected outside organizations with
    the employees reported financial interests on
    the HHS-716, in Part III, Box 1.

12
Example of Party vs. Non-Party
  • An employee is assigned to participate in a
    licensing agreement with Bristol Myers Squibb
    (BMS) (the party). Merck and Amgen would be
    competitors to BMS (the non-parties) because they
    produce the same or a similar product.
  • Ownership of BMS, Merck and/or Amgen stock may
    cause a conflict because the licensing agreement
    affects all of these companies.

13
Supervisory Review, cont.
  • For each financial interest or holding which
    matches or is related to an official
    responsibility, supervisor completes Part IV
    Supervisor Review, on pages 6-7 of the HHS-716
  • 1. Describe potential conflicts.
  • 2. Document the evaluation of each potential
    conflict
  • a. Can the work be reassigned?
  • b. What is the nature of the employees work?
  • c. Would disqualification from the official duty
    matter affected by the financial interest
    materially impair employees ability to perform
    official duties?

14
Supervisory Review, cont.
  • Part IV Supervisor Review
  • Box 1. Description of Potential Conflicts
    thoroughly describe each situation.

15
Supervisory Review, cont.
  • Part IV, Box 2. Three options for resolution
  • Box 2a. Reassignment Can potential conflicts
    be resolved by reassigning the matter that
    affects the employees financial interest to
    another employee? Thoroughly describe what can be
    reassigned.

16
Supervisory Review, cont.
  • Box 2b. Nature of Work Assignments. Does the
    matter that affects the employees financial
    interests involve significant duties of the
    employees position, or is the affected matter
    not a central or critical assignment for the
    employee? Thoroughly describe assignments and
    the level of criticality.

17
Supervisory Review, cont.
  • Box 2c. Material Impairment. Would the employee
    be materially impaired from fulfilling important
    official duties if disqualified from the affected
    matter? Thoroughly describe importance of
    employees participation in the official work.

18
Summary of What You Do
  • Review employees official duties which involve
    or affect outside organizations.
  • Compare outcome of above review to employees
    financial interests.
  • Identify potential conflicts for each financial
    interest.
  • Document your evaluation of each potential
    conflict in Part IV of the form.

19
Finalize Your Review
  • Sign and date the form where indicated at the
    bottom of page 7.
  • Use page 12 for additional comments.
  • Return the signed form to your IC Ethics Office.
  • DO NOT keep a copy of the form.

20
What Happens Next?
  • The IC Deputy Ethics Counselor (DEC) will review
    your evaluation and indicate concurrence or
    non-concurrence below your signature, and will
    forward the report to the NIH Ethics Office
    (NEO).
  • NEO Staff will review the suggested resolutions
    and prepare an evaluation for the NIH DEC (Part
    V, pages 8-9).

21
Conflict Resolution, cont.
  • Resolution options include
  • Total divestiture due to the conflict between
    financial interests and official duties, and the
    employee cannot be disqualified from the matter.
  • Partial divestiture, to keep the value of the
    affected interests at or below the applicable
    regulatory de minimis level. No disqualification
    necessary.
  • Disqualification from some official matters.
  • Waiver of the conflict when the Governments
    interest in the employees involvement outweighs
    the conflict.
  • No additional actions required.

22
Ethics Staff Responsibilities
  • Ethics Office staff may contact the supervisors
    when employees do not respond to requests for
    more information, so the supervisor can enforce
    the requirements.

23
Is further reporting required?
  • The HHS-716 will be used just this one time, for
    initial reporting.
  • Any NIH employee covered by this reporting
    requirement must submit an HHS-717-1, Report of
    Prohibited Financial Interests for Employees of
    the NIH, within 30 days of acquiring a prohibited
    holding (e.g., gift, inheritance, purchase,
    marriage).
  • Both of the above are separate from filing a
    financial disclosure report (SF-278/OGE-450).

24
Is help available?
  • Yes. You may contact your IC Ethics Office staff
    for assistance in identifying conflicts. Names
    and contact information are available on the NIH
    Ethics Program web site
  • Deputy Ethics Counselors http//ethics.od.nih.gov
    /decs.htm
  • Ethics Specialists http//ethics.od.nih.gov/coor
    d.htm

25
Additional Assistance
  • Detailed procedures for reviewing the HHS-716 are
    available on the NIH Ethics Program Website at
  • http//ethics.od.nih.gov/topics/finandisc-oct05.h
    tm
  • You may contact an Ethics Specialist in the NIH
    Ethics Office by calling 301-402-6628

26
Certificate
  • You have now finished the Supervisors
    Training for Reviewing the HHS-716. Print this
    certificate and send it to your IC Ethics Office.
    Click on File, then Print. Chose Print
    Current Slide to print just this page.
  • Full Name _______________________________
  • IC________ Division/Branch/Office___________
Write a Comment
User Comments (0)
About PowerShow.com